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Editorial on the Research Topic
Neuroglia Molecular Mechanisms in Psychiatric Disorders
Neuroglia are an extended class of cells of ectodermal (astroglia, oligodendroglia, and peripheral
glial cells) and mesodermal (microglia) origin, which provide extensive homeostatic support,
protection, and defense of nervous tissue (Kettenmann and Ransom, 2013; Verkhratsky and Butt,
2013; Verkhratsky and Nedergaard, 2018). Pathological potential of glial cells has been recognized
since their discovery (Virchow, 1858; Andriezen, 1893; Nissl, 1899; Alzheimer, 1910), while recent
decade highlighted the fundamental role of neuroglia in the progression of all types of neurological
diseases (Giaume et al., 2007; Verkhratsky et al., 2013, 2014, 2016, 2017; Burda and Sofroniew, 2014;
Sofroniew, 2014; Zeidan-Chulia et al., 2014; Burda et al., 2016; Pekny et al., 2016; Verkhratsky
and Parpura, 2016; Ferrer, 2018). The neurogliopathology is complex and is represented by glial
reactivity (activation of microglia, astrogliosis) or glial degeneration, atrophy, and loss of functions.
In particular glial cells undergo prominent changes in the context of neuropsychiatric diseases;
these changes are generally represented by loss and asthenia of astroglia and oligodendroglia in
conjunction with microglial activation (Rajkowska and Stockmeier, 2013; Verkhratsky et al., 2015;
Cobb et al., 2016; Rajkowska et al., 2018). In this research topic we addressed the contribution
of neuroglia to major neuropsychiatric conditions including major depression, schizophrenia, and
alcohol use disorders.
The gliocentric theory of major depression has been overviewed by Czéh and Nagy who
presented recent findings on glial structural and functional abnormalities at molecular and
cellular levels. Subsequently they focused on clinical studies and summarized neuroimaging
as well as post-mortem molecular and histopathological evidence supporting leading role of
glia in the progression of depression and related mood disorders. Notably, the depression is
associated with substantial loss of macroglial cells with loss of their function, in conjunction with
microglial activation, which summarily affect neuronal networks and brain function. Structural
and molecular alterations of astrocytes and oligodendrocytes also lie at the core of alcohol
use disorders (Miguel-Hidalgo). In particular alcohol exposure, as well as alcohol withdrawal
affects glial transporters, glutamate (GABA) glutamine shuttle and gap junctions, which connect
glial syncytia. The association of endothelial cells, blood-brain barrier and neurovascular unit
with neuropsychiatric diseases has been discussed by Malik and Di Benedetto, who presented
evidence supporting pathophysiological role of disrupted erythropoietin-producing-hepatocellular
carcinoma receptors (EphR)/Ephrin signaling cascades.
Pathophysiological changes in microglia in context of environmental stress associated
with neurodevelopmental and neuropsychiatric disorders are overviewed by Tay et al. In
particular, they discuss the role of microglia in Nasu-Hakola disease, hereditary diffuse
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leukoencephaly with spheroids, Rett syndrome, autism spectrum
disorders, obsessive-compulsive disorder and major psychiatric
pathologies such as addiction, major depressive disorder, bipolar
disorder, schizophrenia, eating disorders, and sleep disorders.
Studies on humans have demonstrated neuroinflammation
and microglial reactivity in patients with schizophrenia as
well as in animal models. In the latter, the gender differences
have been also described (Hui et al.); and it turned out that
in males prominent differences in microglial distribution,
morphology, and microglial activation may account for
higher incidence of schizophrenia. Up-regulation of microglia
associated genes following administration of IgG-Saporin has
been demonstrated to alter a memory-associated behavior
(Dobryakova et al.). The role of microglial activation and
phagocytosis in Parkinson’s disease and therapeutic potential of
targeting microglia were reviewed by Janda et al. Of note both
asphyxia and cesarean section are associated with the expression
of Schizophrenia risk genes (Paparelli et al.). The link between
neuregulin and β-secretase with schizophrenia is shown by
Zhang et al.
Glial cells can be targets for specific therapy. Effects of
electro-acupuncture on hippocampal neuroinflamamtion in
rat depressed model (induced by unpredictable stress-induced
depressive- and anxiety-like behavior) are presented by Yue
et al. They showed that treatment with acupuncture reduce
behavioral abnormalities and abrogate neuroinflammation.
Quercitin neuroprotection was discussed by Gao et al.
All in all, the papers assembled in this Research Topic provide
a wide picture of the importance of neuroglia in the pathogenesis
of neuropsychiatric diseases and discuss possible therapeutic
strategies aimed at glial cells.
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